Cargando…
Correlation between adverse events after drug treatment and the MDR1 C3435T polymorphism in advanced non-small cell lung cancer patients in an Asian population: a meta-analysis
OBJECTIVE: To determine the association between the multidrug resistance 1 gene (MDR1) C3435T polymorphism and adverse drug reactions in advanced non-small cell lung cancer (NSCLC) patients in Asia. METHODS: Literature about the relationship between the MDR1 C3435T polymorphism and adverse drug reac...
Autores principales: | Luo, Hua, Qin, Guangmei, Yao, Caoyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726823/ https://www.ncbi.nlm.nih.gov/pubmed/31315482 http://dx.doi.org/10.1177/0300060519858012 |
Ejemplares similares
-
ABCB1 Gene C3435T Polymorphism and Drug Resistance in Epilepsy: Evidence Based on 8604 Subjects
por: Li, Shu-xia, et al.
Publicado: (2015) -
Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer
por: Li, Fei, et al.
Publicado: (2017) -
A meta-analysis of MDR1 polymorphisms rs1128503 and rs1045642 and susceptibility to hepatocellular carcinoma
por: Chang, Qing, et al.
Publicado: (2019) -
MDR1C3435T Polymorphism and Inflammatory Bowel Disease
por: Malik, Manzoor A.
Publicado: (2015) -
Adverse Events Related to Tirzepatide
por: Mishra, Rahul, et al.
Publicado: (2023)